Hyo Sup Shim

7.2k total citations · 1 hit paper
164 papers, 5.1k citations indexed

About

Hyo Sup Shim is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Hyo Sup Shim has authored 164 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 111 papers in Pulmonary and Respiratory Medicine, 69 papers in Oncology and 34 papers in Molecular Biology. Recurrent topics in Hyo Sup Shim's work include Lung Cancer Treatments and Mutations (78 papers), Lung Cancer Diagnosis and Treatment (32 papers) and Lung Cancer Research Studies (32 papers). Hyo Sup Shim is often cited by papers focused on Lung Cancer Treatments and Mutations (78 papers), Lung Cancer Diagnosis and Treatment (32 papers) and Lung Cancer Research Studies (32 papers). Hyo Sup Shim collaborates with scholars based in South Korea, United States and Singapore. Hyo Sup Shim's co-authors include Byoung Chul Cho, Hye Ryun Kim, Yoon Jin, Chang Young Lee, Zongli Zheng, A. John Iafrate, Long P. Le, Sun Min Lim, Se Hoon Kim and Matthew Liebers and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Hyo Sup Shim

160 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anchored multiplex PCR for targeted next-generation sequencing

2014 624 citations Zongli Zheng, Matthew Liebers et al. profile →

Peers

Hyo Sup Shim

PRM

ONCOL

RNMI

Hidetoshi Hayashi Japan

Antonio Chella Italy

Noriko Motoi Japan

Noemı́ Reguart Spain

Stephen L. Graziano United States

Simon Ekman Sweden

Luis E. Raez United States

Charu Aggarwal United States

Junichi Soh Japan

Akira Sakurada Japan

Hidetoshi Hayashi Japan

Hyo Sup Shim

2.8k ×0.9

PRM

3.7k ×1.6

ONCOL

1.4k ×0.9

705 ×0.6

343 ×0.8

RNMI

Citations per year, relative to Hyo Sup Shim Hyo Sup Shim (= 1×) peers Hidetoshi Hayashi

Countries citing papers authored by Hyo Sup Shim

Since Specialization

Citations

This map shows the geographic impact of Hyo Sup Shim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hyo Sup Shim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hyo Sup Shim more than expected).

Fields of papers citing papers by Hyo Sup Shim

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hyo Sup Shim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hyo Sup Shim. The network helps show where Hyo Sup Shim may publish in the future.

Co-authorship network of co-authors of Hyo Sup Shim

This figure shows the co-authorship network connecting the top 25 collaborators of Hyo Sup Shim. A scholar is included among the top collaborators of Hyo Sup Shim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hyo Sup Shim. Hyo Sup Shim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shim, Hyo Sup, et al.. (2025). Genomic classification of intrapulmonary metastasis and multiple primary lung cancer. Clinical and Translational Medicine. 15(9). e70463–e70463. 1 indexed citations

Suh, Young Joo, Kyunghwa Han, Hwiyoung Kim, et al.. (2024). Computed Tomography Radiomics for Preoperative Prediction of Spread Through Air Spaces in the Early Stage of Surgically Resected Lung Adenocarcinomas. Yonsei Medical Journal. 65(3). 163–163. 7 indexed citations

Shin, Ju Hye, Mi Hwa Shin, Song Yee Kim, et al.. (2024). Regenerative Capacity of Alveolar Type 2 Cells Is Proportionally Reduced Following Disease Progression in Idiopathic Pulmonary Fibrosis-Derived Organoid Cultures. Tuberculosis & respiratory diseases. 88(1). 130–137. 1 indexed citations

Jang, Mi, et al.. (2023). Trends and Clinical Characteristics of Next-Generation Sequencing–Based Genetic Panel Tests: An Analysis of Korean Nationwide Claims Data. Cancer Research and Treatment. 56(1). 27–36. 1 indexed citations

Choi, Jinwook, Kijong Yi, Ju‐Gyeong Kang, et al.. (2022). Airway secretory cell fate conversion via YAP‐mTORC1‐dependent essential amino acid metabolism. The EMBO Journal. 41(8). e109365–e109365. 11 indexed citations

Chung, Taek, Hyungjin Rhee, Hyo Sup Shim, et al.. (2021). Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern. Gut and Liver. 16(4). 613–624. 19 indexed citations

Park, Soo‐Yeon, Jung Yeon Hong, Seung‐Hyun Lee, et al.. (2021). Club cell-specific role of programmed cell death 5 in pulmonary fibrosis. Nature Communications. 12(1). 2923–2923. 22 indexed citations

Yoon, Minjae, Seung Hyun Lee, Hyo Sup Shim, & Seok‐Min Kang. (2021). Erdheim–Chester disease presenting as an intracardiac mass and pericardial effusion confirmed by biopsy: a case report. European Heart Journal - Case Reports. 5(10). ytab351–ytab351. 5 indexed citations

Yun, Mi Ran, Dong Hwi Kim, Seok‐Young Kim, et al.. (2020). Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front–Mutant ROS1-Rearranged Non–Small Cell Lung Cancer. Clinical Cancer Research. 26(13). 3287–3295. 74 indexed citations

10.

Jung, In Young, Hyo Sup Shim, Yunsuk Cho, et al.. (2020). Identification of Fungal Species and Detection of Azole-Resistance Mutations in the Aspergillus fumigatus cyp51A Gene at a South Korean Hospital. Yonsei Medical Journal. 61(8). 698–698. 3 indexed citations

11.

Pyo, Kyoung‐Ho, Sun Min Lim, Jae Hwan Kim, et al.. (2020). Comprehensive analyses of immunodynamics and immunoreactivity in response to treatment in ALK-positive non-small-cell lung cancer. Journal for ImmunoTherapy of Cancer. 8(2). e000970–e000970. 23 indexed citations

12.

Chae, Sehyun, Jihyun Moon, Hankyu Lee, et al.. (2020). Combination of PD-L1 and PVR determines sensitivity to PD-1 blockade. JCI Insight. 5(14). 32 indexed citations

13.

Lim, Sun Min, Jae Woo Choi, Min Hee Hong, et al.. (2019). Indoor radon exposure increases tumor mutation burden in never-smoker patients with lung adenocarcinoma. Lung Cancer. 131. 139–146. 26 indexed citations

14.

Yun, Mi Ran, You Won Lee, Chae Won Park, et al.. (2019). Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK ‐rearranged lung cancer. EMBO Molecular Medicine. 11(12). e10581–e10581. 46 indexed citations

15.

Choe, Eun‐Ah, Yoon Jin, Jae Hwan Kim, et al.. (2019). Dynamic changes in PD-L1 expression and CD8+ T cell infiltration in non-small cell lung cancer following chemoradiation therapy. Lung Cancer. 136. 30–36. 35 indexed citations

16.

Kim, Eun‐Kyung, Kyunga Kim, Chang Young Lee, & Hyo Sup Shim. (2017). The frequency and clinical impact of HER2 alterations in lung adenocarcinoma. PLoS ONE. 12(2). e0171280–e0171280. 84 indexed citations

17.

Cho, Byoung Chul, Sun Min Lim, Hye Ryun Kim, et al.. (2017). MA07.07 Ceritinib in ROS1-Rearranged Non-Small-Cell Lung Cancer: An Update of Korean Nationwide Phase II Study. Journal of Thoracic Oncology. 12(1). S381–S382. 1 indexed citations

18.

Shim, Hyo Sup, Zongli Zheng, Matthew Liebers, et al.. (2015). Unique Genetic and Survival Characteristics of Invasive Mucinous Adenocarcinoma of the Lung. Journal of Thoracic Oncology. 10(8). 1156–1162. 142 indexed citations

19.

Jin, Yoon, Byoung Chul Cho, Hye Ryun Kim, Hye‐Jeong Lee, & Hyo Sup Shim. (2015). A Case of ALK-Rearranged Adenocarcinoma with Small Cell Carcinoma-Like Transformation and Resistance to Crizotinib. Journal of Thoracic Oncology. 11(5). e55–e58. 68 indexed citations

20.

Lee, In Seon, Hyo Sup Shim, Hye‐Jeong Lee, & Young Ae Kang. (2014). Multifocal Micronodular Pneumocyte Hyperplasia Mimicking Miliary Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 189(2). 225–226. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact